Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 08:15 am Purchase | 2021-12-31 | 13G | SOS Limited SOS | Mitchell P. Kopin | 159,773 4.900% | 69,416 (+76.82%) | Filing History |
| 2022-02-11 08:11 am Purchase | 2021-12-31 | 13G | Synaptogenix, Inc. SNPX | Mitchell P. Kopin | 29,614 9.990% | 7,866 (+36.17%) | Filing History |
| 2022-02-11 08:08 am Sale | 2021-12-31 | 13G | SenesTech, Inc. SNES | Mitchell P. Kopin | 125 2.400% | -218 (-63.63%) | Filing History |
| 2022-02-11 08:06 am Sale | 2021-12-31 | 13G | Lifeward Ltd. LFWD | Mitchell P. Kopin | 340,754 3.700% | -21,709 (-5.99%) | Filing History |
| 2022-02-11 08:04 am Purchase | 2021-12-31 | 13G | Arcadia Biosciences, Inc. RKDA | Mitchell P. Kopin | 26,464 4.600% | 7,831 (+42.03%) | Filing History |
| 2022-02-11 07:56 am Purchase | 2021-12-31 | 13G | Pulmatrix, Inc. PULM | Mitchell P. Kopin | 167,077 5.600% | 48,577 (+40.99%) | Filing History |
| 2022-02-11 07:54 am Purchase | 2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,407 7.200% | 4,091 (+176.62%) | Filing History |
| 2022-02-11 07:53 am Unchanged | 2021-12-31 | 13G | Plus Therapeutics, Inc. PSTV | Mitchell P. Kopin | 20,000 1.900% | 0 (Unchanged) | Filing History |
| 2022-02-11 07:50 am Sale | 2021-12-31 | 13G | Predictive Oncology Inc. POAI | Mitchell P. Kopin | 7,945 3.500% | -3,645 (-31.45%) | Filing History |
| 2022-02-11 07:49 am Purchase | 2021-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 1,231,482 5.600% | 168,272 (+15.83%) | Filing History |
| 2022-02-11 07:46 am Purchase | 2021-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 7,517 5.700% | 3,393 (+82.28%) | Filing History |
| 2022-02-11 07:44 am Purchase | 2021-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 262 1.400% | 262 (New Position) | Filing History |
| 2022-02-11 07:39 am Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Mitchell P. Kopin | 431,213 4.400% | 431,213 (New Position) | Filing History |
| 2022-02-11 07:36 am Unchanged | 2021-12-31 | 13G | Vyant Bio, Inc. VYNT | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 07:24 am Sale | 2021-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 34,597 2.500% | -27,631 (-44.40%) | Filing History |
| 2022-02-11 07:19 am Purchase | 2021-12-31 | 13G | My Size, Inc. MYSZ | Mitchell P. Kopin | 3,194 2.600% | 63 (+2.01%) | Filing History |
| 2022-02-11 07:17 am Purchase | 2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Mitchell P. Kopin | 12,165 1.000% | 12,165 (New Position) | Filing History |
| 2022-02-11 07:16 am Unchanged | 2021-12-31 | 13G | Newegg Commerce, Inc. NEGG | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 07:14 am Purchase | 2021-12-31 | 13G | Indaptus Therapeutics, Inc. INDP | Mitchell P. Kopin | 2,151 0.700% | 2,151 (New Position) | Filing History |
| 2022-02-11 07:06 am Purchase | 2021-12-31 | 13G | Histogen Inc. HSTO | Mitchell P. Kopin | 264,136 9.990% | 141,408 (+115.22%) | Filing History |